Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes

Journal of Clinical Hypertension

Volumn 14, Issue 7, 2012, Pages 455-460

  Chen, Yinghua ^a   Feng, Bo ^a   Li, Xu ^a   Ni, Yafang ^a   Luo, Yun ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPOCORTIN 5; METFORMIN; SULFONYLUREA;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BLOOD SAMPLING; BRACHIAL ANKLE PULSE WAVE VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DIURETIC THERAPY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LEUKOCYTE MICROPARTICLE; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE MICROPARTICLE; MICROPARTICLE ENZYME IMMUNOASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PLASMA ENDOTHELIAL MICROPARTICLE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE;

ANKLE BRACHIAL INDEX; ARTERIES; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; CHINA; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84863433613     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00631.x     Document Type: Article

References (19)

1. Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122:443-453.
2. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527-539.
3. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
4. Janghorbani M, Amini M. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors. Diabetes Res Clin Pract. 2005;70:71-80.
5. Sahakyan K, Klein BE, Myers CE, et al. Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus. Am Heart J. 2010;159:1074-1080.
6. Leroyer AS, Tedgui A, Boulanger CM. Microparticles and type 2 diabetes. Diabetes Metab. 2008;1:S27-S32.
7. Wang JM, Su C, Wang Y, et al. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients. J Hum Hypertens. 2009;23:307-315.
8. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008;173:1210-1219.
9. Leroyer AS, Anfosso F, Lacroix R, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost. 2010;104:456-463.
10. Densmore JC, Signorino PR, Ou J, et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock. 2006;26:464-471.
11. Jimenez JJ, Jy W, Mauro LM, et al. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol. 2001;112:81-90.
12. Feng B, Chen Y, Luo Y, et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208:264-269.
13. Nozaki T, Sugiyama S, Koga H, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54:601-608.
14. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;17:1622-1630.
15. Pirro M, Schillaci G, Paltriccia R, et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2006;26:2530-2535.
16. Mezentsev A, Merks RM, O'Riordan E, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol. 2005;289:H1106-H1114.
17. Munakata M, Ito N, Nunokawa T, et al. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens. 2003;16:653-657.
18. Wang JM, Huang YJ, Wang Y, et al. Increased circulating CD31+/CD42-microparticles are associated with impaired systemic artery elasticity in healthy subjects. Am J Hypertens. 2007;20:957-964.
19. Buesing KL, Densmore JC, Kaul S, et al. Endothelial microparticles induce inflammation in acute lung injury. J Surg Res. 2011;166:32-39.